# Analyze PTM

Post-translational modification analysis revealing protein regulation, signaling dynamics, and age-related modification changes in proteomes.

## Agent Used

This command leverages the **Proteomics Analyst** agent for PTM analysis.

## Description

Performs comprehensive analysis of protein post-translational modifications from mass spectrometry data. Identifies modified peptides, quantifies modification stoichiometry, detects differential modifications, maps signaling pathways, and characterizes age-related PTM dysregulation. Essential for understanding protein regulation, signal transduction, and quality control in aging.

## Usage

```
/analyze-ptm
```

After invoking the command, provide:
- PTM-enriched proteomics data
- Modification types (phosphorylation, acetylation, etc.)
- Sample metadata (age, treatment, tissue)
- Analysis goals (differential, kinases, pathways)

## Inputs

**Required:**
- PTM proteomics data: Modified peptide identifications
- Modification specifications: PTM types searched
- Sample information: Groups, replicates

**Optional:**
- Protein-level data: For normalization
- Kinase-substrate databases: For kinase prediction
- Site conservation: Evolutionary constraint
- Structural data: For functional context

## Process

The command performs:

1. **Quality control**: PTM identification reliability
2. **Site localization**: Precise modification positions
3. **Quantification**: PTM abundance per site
4. **Normalization**: Accounts for protein-level changes
5. **Differential analysis**: Tests PTM changes
6. **Kinase-substrate enrichment**: Predicts regulators
7. **Pathway analysis**: Affected signaling cascades
8. **Functional annotation**: Regulatory consequences

## Outputs

**PTM identifications:**
- Modified sites per protein
- Modification types and positions
- Localization probabilities
- Site occupancy estimates

**Quantification:**
- PTM abundance values
- Normalized to protein levels
- Stoichiometry estimates
- Technical quality metrics

**Differential PTMs:**
- Sites changing between conditions
- Fold changes and p-values
- Volcano plots and heatmaps
- Age-associated modifications

**Kinase analysis:**
- Predicted kinases per site
- Kinase activity scores
- Kinase-substrate networks
- Upstream regulator analysis

**Pathway enrichment:**
- Signaling pathways affected
- Functional consequences
- Cross-talk between pathways
- Aging signaling dysregulation

**Motif analysis:**
- Sequence motifs around sites
- Kinase recognition sequences
- Structural context
- Conservation patterns

## Interpretation Guidelines

The command reveals:
- Protein modification landscapes
- Signaling pathway activities
- Regulatory enzyme activities
- Functional PTM consequences

For aging research specifically:
- Hyperphosphorylation in aging
- Acetylation changes affecting metabolism
- Oxidative modifications accumulating
- Ubiquitination dysregulation

## Example Use Cases

**Phosphoproteomics:**
Map phosphorylation changes with age revealing altered kinase signaling.

**Acetylation aging:**
Characterize protein acetylation changes affecting metabolism and gene regulation.

**Oxidative damage:**
Quantify oxidative modifications accumulating with age.

**Intervention signaling:**
Determine which signaling pathways are modulated by longevity interventions.

## Integration with Other Commands

Results complement:
- Protein abundance from standard proteomics
- `/build-ppi-network` for signaling network context
- `/pathway-enrichment` for biological interpretation
- `/predict-protein-structure` for structural impacts

## Best Practices

**Experimental design:**
- Use appropriate enrichment strategies
- Include adequate replicates
- Sequence to sufficient depth
- Include unmodified controls

**Data processing:**
- Use stringent localization thresholds
- Normalize to protein abundance
- Filter low-confidence sites
- Validate key modifications

**Statistical analysis:**
- Account for protein-level changes
- Correct for multiple testing
- Report stoichiometry where possible
- Consider site-specific vs protein-level

**Biological interpretation:**
- Integrate with protein networks
- Consider kinase-substrate relationships
- Validate predicted kinases
- Relate to phenotypes

## Technical Notes

Implements PTM-specific analysis workflows using MaxQuant, Spectronaut, or FragPipe. Performs site localization scoring. Normalizes PTM abundances to protein levels. Predicts kinases using sequence motifs and databases.

For aging PTM analysis, recognizes increasing protein damage modifications, altered signaling, and dysregulated enzymes modifying proteins with age.

## PTM Types

**Phosphorylation:**
Serine, threonine, tyrosine. Regulates signaling, localization, activity. Most studied PTM.

**Acetylation:**
Lysine acetylation. Affects metabolism, transcription, chromatin. NAD+-dependent deacetylation.

**Ubiquitination:**
Marks proteins for degradation or trafficking. Multiple ubiquitin chain types with different functions.

**Methylation:**
Lysine and arginine methylation. Regulates transcription, chromatin, signaling.

**Oxidation:**
Cysteine oxidation, methionine oxidation. Damage or redox signaling.

**Glycosylation:**
N-glycosylation, O-glycosylation. Affects folding, stability, trafficking.

## Site Localization

**Localization probability:**
Confidence that PTM is at specific residue. Ambiguity for nearby sites.

**Delta score:**
Difference between top and second-best localization. High delta indicates confident assignment.

**Isoform specificity:**
PTM may be isoform-specific requiring transcript-level analysis.

## Stoichiometry

**Occupancy:**
Fraction of protein molecules modified at site. Critical for understanding functional impact.

**Absolute quantification:**
Requires standards or spike-ins. Challenging but most informative.

**Relative quantification:**
Compares across conditions. Easier but less interpretable.

**Dynamic range:**
PTMs span huge range from <1% to >90% occupancy.

## Kinase-Substrate Prediction

**Sequence motifs:**
Kinases recognize specific amino acid patterns around phosphorylation sites.

**NetworKIN:**
Combines sequence and network context to predict kinases.

**GPS:**
Group-based prediction system using known substrates.

**Experimental validation:**
In vitro kinase assays or kinase inhibitors confirm predictions.

## Phosphorylation Signaling

**MAPK pathways:**
ERK, JNK, p38 cascades. Altered in aging affecting stress responses.

**PI3K/AKT/mTOR:**
Nutrient sensing and growth. Central to longevity interventions.

**AMPK:**
Energy sensor. Activation extends lifespan in multiple organisms.

**Insulin/IGF-1:**
Growth factor signaling. Reduced signaling associated with longevity.

## Acetylation Metabolism

**Histone acetylation:**
Regulates chromatin state and transcription. Changes with aging.

**Metabolic enzymes:**
Acetylation regulates glycolysis, TCA cycle, fatty acid metabolism.

**Sirtuins:**
NAD+-dependent deacetylases. Longevity regulators removing acetylation.

**Mitochondrial acetylation:**
Affects energetics. Increases with age, reversed by CR.

## Oxidative Modifications

**Cysteine oxidation:**
Reversible oxidation regulates activity. Irreversible oxidation is damage.

**Methionine oxidation:**
Biomarker of oxidative stress. Accumulates in aged proteins.

**Carbonylation:**
Irreversible damage marking proteins for degradation.

**Nitrosylation:**
S-nitrosylation regulates signaling. Dysregulated in aging.

## Ubiquitination

**Proteasomal degradation:**
K48-linked chains target proteins for proteasome.

**Autophagy:**
K63-linked chains and other signals direct to autophagy.

**Signaling:**
Non-degradative ubiquitination regulates activity and localization.

**Aging dysfunction:**
Proteasome and autophagy decline with age affecting clearance.

## Age-Related PTM Changes

**Hyperphosphorylation:**
Increased phosphorylation in aging, particularly tau in neurons.

**Acetylation accumulation:**
Protein acetylation increases with age affecting metabolism.

**Oxidative damage:**
Progressive accumulation of oxidative modifications.

**Ubiquitination:**
Dysregulated ubiquitination from declining proteostasis.

**Glycation:**
Non-enzymatic glycation (AGEs) accumulates with age.

## Limitations

- PTM-enrichment required for low-abundance modifications
- Stoichiometry estimation challenging
- Functional consequences not always clear
- Kinase predictions imperfect
- Dynamic modifications may be missed in steady-state

Integration of multiple PTM types and time-resolved analysis improves insights.

## Advanced Features

**Multi-PTM analysis:**
Analyzes multiple modification types simultaneously revealing cross-talk.

**Temporal dynamics:**
Time-course analysis captures signaling dynamics.

**Spatial PTMs:**
Emerging methods preserve tissue localization.

**Crosstalk:**
Interactions between different PTM types on same or nearby sites.

**Single-cell PTMs:**
Emerging technologies enabling PTM analysis at single-cell resolution.

## Functional Validation

**Mutagenesis:**
Mutate sites to non-modifiable residues testing functional importance.

**Kinase inhibitors:**
Pharmacologically test predicted kinase-substrate relationships.

**PTM-specific antibodies:**
Validate predicted sites and quantify in vivo.

**Functional assays:**
Test whether PTM changes affect activity, localization, or interactions.

## Therapeutic Targeting

**Kinase inhibitors:**
Target hyperactive kinases in aging or disease.

**Deacetylase activation:**
Sirtuin activators for metabolic benefits.

**Proteasome enhancement:**
Restore proteostasis by improving degradation.

**Oxidative stress:**
Antioxidants or interventions reducing oxidative PTMs.

---

This command enables comprehensive PTM analysis revealing protein regulatory mechanisms and age-related signaling dysregulation essential for understanding functional consequences of aging proteomes.